This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08191/identifier/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08191/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08191/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08191/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB08191/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08191
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08191 n7:DB08191
dcterms:title
4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid
adms:identifier
n9:DB08191 n10:MMG n11:9718949 n13:11544170 n14:99444662
n3:IUPAC-Name
n4:271B401A-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4020-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B401F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B401C-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B401D-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B401E-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4018-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4016-363D-11E5-9242-09173F13E4C5 n4:271B4019-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4017-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4026-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4027-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4021-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4022-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4024-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4023-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4025-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B402C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B402E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B402F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B402B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B402A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B402D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B401B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4028-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4029-363D-11E5-9242-09173F13E4C5